Cheng‐Da Hsu

641 total citations
25 papers, 517 citations indexed

About

Cheng‐Da Hsu is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cheng‐Da Hsu has authored 25 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cheng‐Da Hsu's work include Bladder and Urothelial Cancer Treatments (6 papers), Epigenetics and DNA Methylation (3 papers) and Connexins and lens biology (3 papers). Cheng‐Da Hsu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Epigenetics and DNA Methylation (3 papers) and Connexins and lens biology (3 papers). Cheng‐Da Hsu collaborates with scholars based in Taiwan, United States and China. Cheng‐Da Hsu's co-authors include Hsiao‐Yen Hsieh, J. Mark Petrash, Seth Blackshaw, Akishi Onishi, Shiming Chen, Cheng-Huang Shen, Yuan‐Hung Wang, Steven Kymes, Cheng‐Huang Shen and Joseph E. O’Tousa and has published in prestigious journals such as Neuron, Journal of Neuroscience and Biochemistry.

In The Last Decade

Cheng‐Da Hsu

25 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng‐Da Hsu Taiwan 14 382 101 92 56 55 25 517
Jean-Pierre Roperch France 9 335 0.9× 164 1.6× 75 0.8× 71 1.3× 56 1.0× 10 503
Carita Lannér Canada 8 362 0.9× 71 0.7× 59 0.6× 53 0.9× 24 0.4× 14 560
Anna M. Sokòl Germany 13 407 1.1× 71 0.7× 46 0.5× 71 1.3× 31 0.6× 24 597
Andrea Šoltýsová Slovakia 14 354 0.9× 116 1.1× 38 0.4× 77 1.4× 28 0.5× 37 624
Nicholas N. Lyssenko United States 15 341 0.9× 72 0.7× 159 1.7× 62 1.1× 25 0.5× 25 633
Xueyan Guo China 12 268 0.7× 84 0.8× 54 0.6× 93 1.7× 34 0.6× 29 463
Rong Chu United States 12 277 0.7× 184 1.8× 79 0.9× 35 0.6× 24 0.4× 25 463
Rodolfo Daniel Cervantes‐Villagrana Mexico 12 250 0.7× 116 1.1× 47 0.5× 51 0.9× 48 0.9× 26 496

Countries citing papers authored by Cheng‐Da Hsu

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Da Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Da Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Da Hsu more than expected).

Fields of papers citing papers by Cheng‐Da Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Da Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Da Hsu. The network helps show where Cheng‐Da Hsu may publish in the future.

Co-authorship network of co-authors of Cheng‐Da Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Da Hsu. A scholar is included among the top collaborators of Cheng‐Da Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Da Hsu. Cheng‐Da Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Cheng‐Huang, Hsiao‐Yen Hsieh, Dennis W. Hwang, et al.. (2016). Guizhi Fuling Wan as a Novel Agent for Intravesical Treatment for Bladder Cancer in a Mouse Model. Molecular Medicine. 22(1). 64–73. 12 indexed citations
2.
Hsieh, Hsiao‐Yen, Cheng-Huang Shen, Shih‐Yuan Huang, et al.. (2015). Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3β to suppress mTOR and β-catenin signaling pathways. Cancer Letters. 370(1). 56–65. 26 indexed citations
3.
4.
5.
Yeh, Chia‐Ming, Pi-Che Chen, Hsiao‐Yen Hsieh, et al.. (2015). Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma. Oncotarget. 6(30). 29555–29572. 37 indexed citations
6.
Hsu, Cheng‐Da, et al.. (2014). Sequence variants of the HTR3A gene contribute to the genetic prediction of postoperative nausea in Taiwan. Journal of Human Genetics. 59(12). 655–660. 12 indexed citations
7.
Tsai, Yuh‐Shyan, et al.. (2014). Age-dependent Association Between Dickkopf-1 and Calcium-containing Urolithiasis. Urology. 83(5). 1006–1010. 4 indexed citations
8.
Hsieh, Hsiao‐Yen, et al.. (2014). Abstract 4561: The antihistamine cyproheptadine induces cell apoptosis through inhibition of β-catenin signaling pathways in urothelial carcinoma. Cancer Research. 74(19_Supplement). 4561–4561. 1 indexed citations
9.
Hsu, Cheng‐Da, et al.. (2014). Abstract 4566A: Effect of the anti-histaminic cyproheptadine on cell cycle of hepatocellular carcinoma cells and its mechanisms. Cancer Research. 74(19_Supplement). 4566A–4566A. 1 indexed citations
10.
Shen, Cheng‐Huang, et al.. (2014). Cortex Moutan Inhibits Bladder Cancer Cell Proliferation and Expression of Angiogenic Factors. Pharmacology & Pharmacy. 5(8). 846–858. 3 indexed citations
11.
Shen, Cheng‐Huang, et al.. (2013). The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder. BMC Complementary and Alternative Medicine. 13(1). 44–44. 13 indexed citations
12.
Chen, Pi-Che, Yeong‐Chin Jou, Chi‐Fai Ng, et al.. (2011). Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine. BMC Medical Genomics. 4(1). 45–45. 36 indexed citations
13.
Shen, Cheng‐Huang, Cheng‐Da Hsu, Yeong‐Chin Jou, et al.. (2011). The high incidence of JC virus infection in urothelial carcinoma tissue in Taiwan. Journal of Medical Virology. 83(12). 2191–2199. 19 indexed citations
14.
Shen, Cheng-Huang, Hsiao‐Yen Hsieh, Yuan‐Hung Wang, et al.. (2010). High Dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinoma. Experimental and Therapeutic Medicine. 1(5). 893–898. 13 indexed citations
15.
Onishi, Akishi, et al.. (2009). Pias3-Dependent SUMOylation Directs Rod Photoreceptor Development. Neuron. 61(2). 234–246. 95 indexed citations
16.
Hsu, Cheng‐Da, et al.. (2009). Interactions between Small Heat Shock Protein α-Crystallin and Galectin-Related Interfiber Protein (GRIFIN) in the Ocular Lens. Biochemistry. 48(18). 3956–3966. 24 indexed citations
17.
Hsu, Cheng‐Da, et al.. (2009). Anti-inflammatory Effect of Ding Chuan Tang in Human Lung Epithelial Cells. 15(2). 97–110. 1 indexed citations
18.
Wang, Yuan‐Hung, Hung‐Yi Chiou, Hsiao‐Yen Hsieh, et al.. (2008). Association Between Survivin Gene Promoter −31 C/G Polymorphism and Urothelial Carcinoma Risk in Taiwanese Population. Urology. 73(3). 670–674. 51 indexed citations
19.
Hsu, Cheng‐Da, et al.. (2004). Limited Role of Developmental Programmed Cell Death Pathways inDrosophila norpARetinal Degeneration. Journal of Neuroscience. 24(2). 500–507. 27 indexed citations
20.
Hsu, Cheng‐Da, Sheila M. Adams, & Joseph E. O’Tousa. (2002). Rpr- and hid-driven cell death in Drosophila photoreceptors. Vision Research. 42(4). 507–516. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean-Pierre Roperch Breakdown of academic impact, for papers by Carita Lannér Breakdown of academic impact, for papers by Anna M. Sokòl Breakdown of academic impact, for papers by Andrea Šoltýsová Breakdown of academic impact, for papers by Nicholas N. Lyssenko Breakdown of academic impact, for papers by Xueyan Guo Breakdown of academic impact, for papers by Rong Chu Breakdown of academic impact, for papers by Rodolfo Daniel Cervantes‐Villagrana
Rankless by CCL
2026